The present study demonstrated that low-grade inflammation that causes macrophage activation under obesity conditions induces β-cell dysfunction and exacerbates diabetes due to enhanced β-cell apoptosis mediated by XAF1 expression, in addition to decreased insulin sensitivity through adipose tissue inflammation. Here, XAF1 is linked to obesity disorder.